尿道狭窄治疗市场：按类型、治疗（尿道扩张、开放式尿道内切开术、尿道切开术、其他）、疾病适应症、最终用户、地区 - 规模、份额、前景、机会分析，2023-2030 年

尿道狭窄是由于感染或受伤留下的疤痕导致的尿道狭窄。 尿道狭窄有两种类型：后尿道狭窄和前尿道狭窄。 后尿道狭窄是由于后尿道纤维化、外伤挫伤或骨盆骨折所致。 前尿道狭窄是最常见的狭窄，由感染或外伤引起的海绵体纤维化引起。 这种情况可以通过多种治疗方法进行治疗，包括直接尿道镜内尿道切开术 (DVIU) 和尿道成形术。 尿道狭窄的主要症状是排尿受阻或刺激、排尿时间增加和膀胱排空不完全感。 它在发达国家男性中的患病率估计为 0.9%。 它可导致阻塞性和刺激性排尿症状，并最终降低肾功能。 尿道狭窄可由泌尿科诊断和治疗程序引起。 随着人口老龄化的到来，这些手术变得越来越普遍，因此尿道狭窄也可能变得更加普遍。

市场动态

市场越来越多地采用监管批准等无机增长策略来扩大其产品组合，预计这将在预测期内推动市场增长。 例如，2022 年 1 月，Laborie.) 已宣布该产品已获批。

这项研究的主要特点

• 本报告对全球尿道狭窄治疗市场进行了深入分析，并展示了以 2022 年为基准年的预测期（2023-2030 年）的市场规模和復合年增长率 (CAGR%)。
• 它阐明了各个细分市场的潜在收入机会，并概述了该市场具有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，介绍全球尿道狭窄治疗市场的主要参与者概况。
• 本研究涵盖的主要公司包括 Becton、Dickinson and Company、Amecath、Zhejiang Chuangxiang、Medical Technology Co., Ltd.、Allium Ltd.、SURGIMEDIK、Cook Group、Taewoong Medical Co., Ltd.、Teleflex Incorporated、 B. Braun Melsungen AG、Coloplast A/S、Boston Scientific Corporation 和 Pnn Medical A/S.，以及 Laborie。这份报告的见解将使营销人员和公司的管理当局能够就其未来的产品发布做出明智的决定，类型升级、市场扩张和营销策略。
• 《全球尿道狭窄治疗市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球尿道狭窄治疗市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写

第二章市场展望

• 报告概述
  • 市场定义和范围
• 执行摘要
  • 市场概况，按类型
  • 市场概况：按疗法分类
  • 市场概况：按疾病适应症分类
  • 市场概况：按最终用户分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场机会
  • 影响分析
  • 主要亮点
  • 产品发布
  • 技术进步
  • 害虫分析
  • 监管情景
  • 併购

第 4 章全球尿道狭窄治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 经济影响
• 关于 COVID-19 的流行病学
• 对供需的影响

第 5 章全球尿道狭窄治疗市场，按类型，2017-2030

• 后尿道狭窄
• 前尿道狭窄

第 6 章全球尿道狭窄治疗市场，按治疗方法，2017-2030

• 尿道扩张
• 直视内尿道切开术 (DVIU)
• 尿道成形术
• 尿道吻合术
• 置换尿道成形术
• 其他

第 7 章全球尿道狭窄治疗市场，按疾病适应症，2017-2030

• 医源性
• 特发性
• 源自传染病
• 创伤
• 其他

第 8 章全球尿道狭窄治疗市场：按最终用户分类，2017-2030

• 医院
• 门诊手术中心
• 其他

第 9 章全球尿道狭窄治疗市场：地区，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第10章竞争格局

• Becton, Dickinson and Company
• Amecath
• Zhejiang Chuangxiang Medical Technology Co., Ltd
• Allium Ltd.
• SURGIMEDIK
• Cook Group
• Teawoong Medical Co., Ltd.
• Teleflex Incorporated
• B. Braun Melsungen AG
• Coloplast A/S
• Boston Scientific Corporation
• Pnn Medical A/S
• Laborie.

第 11 章章节

• 调查方法
• 关于出版商

Urethral stricture is the narrowing of the calibre of the urethra that is caused due to scarring resulting from infection or injury. There are two types of urethral strictures named posterior urethral stricture and anterior urethral stricture. Posterior urethral strictures occur due to fibrosis of the posterior urethra or distraction injuries that result from trauma or pelvic fractures. Anterior urethral stricture are the most commonly occurring strictures, and are caused due to infection or trauma leading to spongiofibrosis. The condition can be treated with various treatment options such as urethral direct vision internal urethrotomy (DVIU), urethroplasty, and other treatments. The main symptoms of urethral stricture are obstructed and irritated micturition, with increased urination time, and a feeling of incomplete bladder emptying. Its prevalence among men in industrial countries is estimated at 0.9%. It produces obstructive and irritative urinary symptoms, and can ultimately impair renal function. Urethral strictures can be caused by diagnostic or therapeutic urological procedures. These procedures are being performed more commonly, because the population is aging, and thus, urethral strictures will probably become more common as well.

Market Dynamics

Increasing adoption of inorganic growth strategies such as approvals by the regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2022, Laborie., a medical technology company thath provide products for urology, gynecology, and others, announced that it has received a license to the Optilume, a urethral drug coated balloon (DCB), laborite., and product is approved from U.S. Food and Drug Administration (FDA).

Key features of the study:

• This report provides in-depth analysis of the global urethral stricture treatment market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global urethral stricture treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Ltd, Allium Ltd., SURGIMEDIK, Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, and Pnn Medical A/S. , and Laborie.Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global urethral stricture treatrment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global urethral stricture treatment market

Detailed Segmentation:

• Global Urethral Stricture Treatment Market, By Type:
  • Posterior Urethral Stricture
  • Anterior Urethral Stricture
• Global Urethral Stricture Treatment Market, By Treatment:
  • Urethral Dilation
  • Direct Vision Internal Urethrotomy (DVIU)
  • Urethroplasty
    • Anastomotic Urethroplasty
    • Substitution Urethroplasty
  • Others
• Global Urethral Stricture Treatment Market, By Disease Indication:
  • Latrogenic
  • Idiopathic
  • Infection-induced
  • Trauma
  • Others
• Global Urethral Stricture Treatment Market, By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
• Global Urethral Stricture Treatment Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Becton, Dickinson and Company*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Amecath
  • Zhejiang Chuangxiang
  • Medical Technology Co., Ltd
  • Koninklijke Philips N.V.
  • Allium Ltd.
  • SURGIMEDIK
  • Cook Group
  • Taewoong Medical Co., Ltd.
  • Teleflex Incorporated
  • Braun Melsungen AG
  • Coloplast A/S
  • Boston Scientific Corporation
  • Pnn Medical A/S

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Treatment
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product Launches
  • Technological Advancements
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Urethral Stricture Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Urethral Stricture Treatment Market, By Type, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Posterior Urethral Stricture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Anterior Urethral Stricture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Urethral Stricture Treatment Market, By Treatment, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Urethral Dilation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Direct Vision Internal Urethrotomy (DVIU)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Urethroplasty
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Anastomotic Urethroplasty
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
• Substitution Urethroplasty
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

7. Global Urethral Stricture Treatment Market, By Disease Indication, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Latrogenic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Idiopathic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Infection-induced
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Trauma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

8. Global Urethral Stricture Treatment Market, By End User, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-O-Y Growth analysis, 2017 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)

9. Global Urethral Stricture Treatment Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Amecath
• Zhejiang Chuangxiang Medical Technology Co., Ltd
• Allium Ltd.
• SURGIMEDIK
• Cook Group
• Teawoong Medical Co., Ltd.
• Teleflex Incorporated
• B. Braun Melsungen AG
• Coloplast A/S
• Boston Scientific Corporation
• Pnn Medical A/S
• Laborie.

11. Section

• Research Methodology
• About Us